Where Creativity and Science Collide
THE COMPANY THAT FINDS CREATIVE SOLUTIONS FOR MODERN ANTIBODY TECHNOLOGIES
Creasallis Ltd is The Creative Antibody Solutions Company. It is a Cambridge, UK-based company with an expert team of antibody engineers in the biopharmaceutical industry. We provide novel protein engineering solutions for antibody-based therapeutics offering enhanced efficacy, safety and lower cost of goods for antibody based drugs.
At Creasallis we believe that antibody-based therapeutics can be greatly enhanced with creative engineering. At the heart of our philosophy is simple solutions for antibody engineering bottlenecks. Our team of antibody engineers have over 15 years of experience in the biopharmaceutical industry developing antibody-based therapeutics and implementing engineering solutions to antibody bottlenecks.
At Creasallis, we believe that by combining our unique insights into antibody structure with molecular biology tools, we can create the second generation of antibody molecules that will out perform the current therapies. Our vision is to use these therapies to save lives and we believe in creating a dynamic and productive organisation to realise this.
Smart solutions are at the core of all that we do at Creasallis. Our first technology is the CreaTap™ Tumour Antibody Penetration technology that improves penetrability of antibodies into the tumour microenvironment. CreaTap™ is unique with full freedom to operate that is fully owned by Creasallis. Contact us now to hear more about the value of CreaTap™.
"The world we have made as a result of the level of thinking we have done thus far creates problems we cannot solve at the same level of thinking at which we created them."
Creasallis Highly Commended Start-up of the Year in Cambridge Independent Science and Technology Awards
MAY 11, 2022
Creasallis was recognised as highly commended as start up of the year in the 2022 Cambridge Independent start up of the year. Our CEO, Zahra Jawad received the award on behalf of Creasallis. Read more about it here:
Creasallis made it onto the long list #21toWatch
NOVEMBER 4, 2021
We are delighted and humbled that Creasalis has been recognised by Cofinitive #21toWatch long list. Thank you for the nomination!
Genesis Biotech Rising Stars 2021!
DECEMBER 6, 2021
Will you be at Genesis 2021? Watch out for Creasallis as the Biotech 2021 Rising stars. Hear our short pitch on why Creasallis is different and how it wants to make a difference
Creasallis at hubXchange
NOVEMBER 30, 2021
Hear what Creasallis has to say on Fc engineering of antibodies as they lead a session on Fc engineering. Join us at hubXchange Europe on the 30th November 2021
Creasallis wins top accelerator award
Creasallis has won a place as part of cohort 4 on the accelerate@Babraham accelerator. this will enable Creasallis to collaborate and start up its next generation antibody engineering capabilities